Echo Therapuetics

 
Posted Tuesday, December 15th, 2009 by Editor
Tags: , , , ,


Stock Ticker (OTCBB): ECTE

Website: http://www.echotx.com/

Stock Quote

 


Business Summary

 

Echo Therapeutics is a transdermal medical device and specialty pharmaceuticals company. Echo’s Symphony tCGM System is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system focused on changing the paradigm of invasive, episodic glucose testing in diabetes home use and hospital critical care markets.

Echo’s AzoneTS transdermal drug reformulation technology is focused on building a pipeline of safer and improved versions of widely-prescribed, FDA-approved specialty pharmaceutical products. Echo is developing most of its AzoneTS pipeline in accordance with the FDA’s Section 505(b)(2) guidelines. Durhalieve™, Echo’s lead AzoneTS drug candidate, is an advanced topical reformulation of triamcinolone acetonide for treatment of corticosteroid responsive dermatoses. Echo has submitted its Durhalieve New Drug Application (NDA) to the FDA.


Research

 

Recent News

 


Newsletter

 

No Newsletters found.
 

Recent Blog Entries

 

Echo Therapeutics Cornerstone Product Featured in Scientific American Magazine
Posted Thursday, April 22nd, 2010
Echo Therapeutics,  Inc. (OTCBB: ECTE) - a stock that I personally thought would be trading above $2 by now, recently had its Symphony™ trans-dermal Glucose monitoring system was featured in a March 31, 2010 online magazine article in Scientific A...

LifeTech Capital Initiates Echo Therapeutics (ECTE) with Strong Speculative Buy $4.50 Target
Posted Thursday, January 21st, 2010
Click Here to View Report/Buy Recommendation...

ECTE Breaks 52-Week High and Poised to Move Higher
Posted Thursday, January 14th, 2010
Echo Therapeutics, Inc. (OTCBB: ECTE) is poised to move higher. By hitting a new 52-week high, ECTE has triggered major accumulation among traders and things are heating up.   Remember, there are countless indicators that are very optimistic regar...

Check Out ECTE’s Presentation from OneMed Finance Forum
Posted Thursday, January 14th, 2010
Here's a link to Echo Therapeutics (OTCBB: ECTE) CEO Patrick H. Mooney, M.D's presentation this week at the OneMed Finance Forum in San Francisco: http://www.ustream.tv/recorded/3953983 This gives a gret description of the company, its key product...

ECTE Exhibiting a Strong Upward Trend
Posted Wednesday, January 13th, 2010
Echo Therapeutics, Inc. (OTCBB: ECTE) made it to new 18 month highs yesterday, hitting $2.04 at one point and closing at a new 52 week high of $2.02. Pre-market trading is looking strong so far at $2.06 We suspect there will be excitement at the open...


Disclosure

 
Share and Enjoy:
  • Digg
  • del.icio.us
  • Google Bookmarks
  • E-mail this story to a friend!
  • Facebook
  • TwitThis
  • Reddit
  • Technorati
  • StumbleUpon
  • Print this article!